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1. Introduction 
The human ocular surface spans from the conjunctiva to the cornea and plays a critical role 
in visual perception. Cornea, the anterior portion of the eye, is transparent and provides the 
eye with two-thirds of its focusing power and protection of ocular integrity. The cornea 
consists of five main layers, namely, corneal epithelium, Bowman’s layer, corneal stroma, 
Descemet’s membrane and corneal endothelium. 
The outermost layer of the cornea, which is exposed to the external environment, is the 
corneal epithelium. Corneal epithelial integrity and transparency are maintained by somatic 
stem cells (SC) that reside in the limbus. The limbus, an anatomical structure 1-2 mm wide, 
circumscribes the peripheral cornea and separates it from the conjunctiva (Cotsarelis et al., 
1989, Davanger and Evensen, 1971) (Figure 1). Any damage to the ocular surface by burns, 
or various infections, can threaten vision. The most insidious of such damaging conditions is 
limbal stem cell deficiency (LSCD). Clinical signs of LSCD include corneal vascularization, 
chronic stromal inflammation, ingrowth of conjunctival epithelium onto the corneal surface 
and persistent epithelial defects (Lavker et al., 2004). Primary limbal stem cell deficiency is 
associated with aniridia and ectodermal dysplasia. Acquired limbal stem cell deficiency has 
been associated with inflammatory conditions (Stevens–Johnson syndrome (SJS), ocular 
cicatricial pemphigoid), ocular trauma (chemical and thermal burns), contact lens wear, 
corneal infection, neoplasia, peripheral ulcerative corneal disease and neurotrophic 
keratopathy (Dua et al., 2000, Jeng et al., 2011). Corneal stem cells and/or their niche are 
known to play important anti-angiogenic and anti-inflamatory roles in maintaining a 
normal corneal microenvironment, the destruction of which in LSCD, tips the balance 
toward pro-angiogenic conditions (Lim et al., 2009). 
For a long time, the primary treatment for LSCD has been transplantation of healthy - 
keratolimbal tissue from autologous, allogenic, or cadaveric sources. In the late 1990s, 
cultured, autologous, limbal epithelial cell implants were used successfully to improve 
vision in two patients with chemical injury-induced LSCD (Pellegrini et al., 1997). Since then, 
transplantation of cultivated epithelial (stem) cells has become a treatment of choice for 
numerous LSCD patients worldwide. While the outcomes are promising, the variability of 
methodologies used to expand the cells, points to an underlying need for better 
standardization of ex vivo cultivation-based therapies and their outcome measures (Sangwan 
et al., 2005, Ti et al., 2004, Grueterich et al., 2002b, Kolli et al., 2010). 
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Fig. 1. (A) Photograph of the front of the human eye. The cornea, which is clear, can be seen 
at the front of the eye highlighted by the light reflections. The cornea is continuous with the 
limbus, the narrow band of tissue found encircling the cornea. The limbus is continuous 
with the conjunctiva and its underlying sclera, together forming the anterior portion of the 
eye. (B) Cross section of human limbal palisades of Vogt. 
This chapter provides a general update on LSCD pathogenesis, the key role of stem cells and 
their niche in maintaining corneal homeostasis and avascularity and a general update on 
LSCD pathogenesis. An overview of different methodologies used for ex vivo stem cell 
expansion will shed some light on the future of cell-based therapy for LSCD patients.  
2. What defines limbal stem cell niche 
The ocular surface is anatomically composed of the entire epithelial surface of the cornea, 
limbus and conjunctiva, and is physically continuous with the eyelids and adenexa. The 
limbal epithelium, which separates the corneal epithelium from the conjunctival epithelium, 
is made up of a nonkeratinizing, stratified squamous epithelium, which is much thicker, up 
to 10 cell layers, than the central corneal epithelium. Moreover, limbal epithelium is thought 
to contain the source of the stem cells (SC) that serve as the source of corneal epithelial cell 
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renewal and provide a barrier between conjunctival and corneal epithelia. These cells are 
known as corneal epithelial SCs or limbal stem cells (LSCs). In addition to intrinsic factors 
(i.e., characteristics inherent to the stem cells), extrinsic influences from the 
microenvironment surrounding the stem cells may also play a role in corneal cell renewal 
(Barros et al., 1995, Morrison et al., 1997, Tseng, 1996), as discussed below. 
2.1 Limbal microenvironment and stem cell properties 
Within the limbus, LSCs are thought to reside in a stem cell niche, which maintains them in 
their undifferentiated state. This stem cell niche is anatomically denoted as the palisades of 
Vogt. The palisades of Vogt are radial infoldings (Figure 1 B) located at the limbo-corneal 
junction, extending outwards of 1–2 mm from that junction (Goldberg and Bron, 1982); a 
anatomical feature unique to the human eye that can be used as a clinical marker indicating 
the presence of corneal epithelial stem cells. Davenger and Evensen  (1971) and Bron (1973) 
reported the  significant characterizations of the palisades of Vogt in 1971 (Davanger and 
Evensen, 1971, Bron, 1973). The authors observed heavily pigmented epithelium migrating 
in lines from the limbus to the central cornea in response to corneal epithelial defects.  
2.1.1 Characterization and microenvironment of the palisades of Vogt 
The limbal basement membrane differs from that of the cornea that undulates, with pegs of 
stroma extending upward and interconnecting with anchoring fibrils that link to the 
basement membrane (Gipson, 1989). This structure could provide resident stem cells with 
an adherent niche, protecting them from injury and movement within their 
microenvironment. Differences in the composition of the limbal and central corneal 
basement membranes have been observed, and these are thought to play a role in the 
maintenance of their respective populations of epithelial cells. Moreover the LSC niche lies 
beneath a number of cell layers where oxygen tension is likely to be lower. Limbal cells are 
in close proximity to a blood supply and have access to survival factors such as keratinocyte 
growth factor (KGF), IL-6 and components of basement membrane unavailable to cells of 
the central cornea. Interestingly, hypoxic ex vivo conditions have been found to produce 
larger, less differentiated limbal epithelial cell colonies, suggesting that low oxygen levels 
may induce selective proliferation of undifferentiated cells (Miyashita et al., 2007). 
Photomicrographic, angiographic and histological studies have demonstrated the 
fibrovascular nature of the palisades and the presence of “ridges of thickened epithelium” in 
the interpalisade zone (Goldberg and Bron, 1982, Townsend, 1991). Confocal microscopy 
along with scanning electron microscopy (SEM) provides the opportunity to optically 
section the corneal limbus and create 3D reconstructions of the tissue (Romano et al., 2003, 
Shortt et al., 2007). This approach allows identification of previously unrecognized 
candidates for the LSC niche, limbal crypts (LCs) and focal stromal projections (FSPs), and 
has significantly advanced understanding of the structure of this adult stem cell niche. 
2.1.2 Asymmetric cell division 
Adult SCs exist in an optimal microenvironment or ‘niche’ that promotes their maintenance 
in an undifferentiated state (Fuchs et al., 2004). When SCs undergo asymmetric division, 
only one of the daughter cells can re-enter the niche to replenish the SC population (Figure 
2). The other cell loses the protection of the niche and is destined to differentiate and become 
a transient amplifying cell (TAC). The role of the TAC is to divide at an exponential rate in 
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Fig. 2. Schematic diagram of the SC hierarchy. Modified from (Drug Discovery Today. 
Volume 15,Number 7/8.April 2010. 
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order to provide increased cell numbers. The ability of the TAC to multiply is limited and 
will eventually differentiate into a post-mitotic cell that can no longer multiply (Cotsarelis et 
al., 1989). The PMCs are committed to cellular differentiation and mature to form terminally 
differentiated cells that represent the final phenotypic expression of the tissue type. These 
mechanisms are essential for the understanding of normal stem cell function and 
homeostasis. Moreover the LSC population is positioned to be influenced by a wide variety 
of cells. These influences include cell-to-cell contact, cell–extracellular matrix contact, and 
paracrine signalling factors and their receptors, and they from adjacent conjunctival 
epithelial cells and fibroblasts, corneal epithelium and fibroblasts, limbal blood vessels, 
limbal melanocytes, corneal nerves and Langerhans cells. The limbal fibroblasts in the 
underlying stroma are heterogeneous and express secreted protein acidic and rich in 
cysteine (SPARC), which may contribute to LSC adhesion (Shimmura et al., 2006). 
2.1.3 Cell signalling  
Cytokine of the cornea and limbus implied specific differences in their microenvironments, 
suggesting fibroblast-mediated paracrine regulation of LSCs. For example, corneal 
fibroblasts release hepatocyte growth factor (HGF), whereas limbal fibroblasts secrete 
keratinocyte growth factor (KGF) (Sotozono et al., 1994). Most importantly, epithelial cells at 
the basal layer of the limbus express high levels of the KGF-R, in contrast to central corneal 
epithelium, which expresses fewer of this receptor. KGF is a potent stimulator of 
proliferation in epithelial cells, and its presence in the limbus results in the proliferation of 
LSCs and TACs (Sotozono et al., 1994). HGF is known to stimulate the migration of epithelial 
cells, and it has been proposed that HGF aids the migration of new TACs produced at the 
limbus through the action of KGF (Wilson et al., 1994). The basement membrane separates 
the LSC from stroma and, thus modulates growth factors and cytokines involved in LSC 
regulation and function (Klenkler and Sheardown, 2004). 
Sonic hedgehog, Wnt/ǃ-catenin, TGF-ǃ and Notch signalling pathways have all been 
implicated in niche control of stem cells; however, little is known of their potential roles in 
the LSC niche. Lack of Dkk2, leads to increased Wnt/ǃ-catenin signalling in limbal stroma. 
This demonstrates the importance of limbal niche control over LSC differentiation during 
development. PAX6 expression is also lost in the corneal epithelial cells of mutant mice, 
suggesting the control downstream of Dkk2 (Mukhopadhyay et al., 2006).  PAX6 deficiency 
leads to aniridia, resulting in turn to impaired corneal epithelial function and eventual LSC 
failure, which may be due to altered niche development. A more recent study by Schlotzer-
Schrehardt et al. found patchy immunolocalization of the laminin Ǆ3 chain, BM40/SPARC 
and tenancin C, which were also found to colocalize with ABCG2/p63/K19-positive cell 
clusters. These factors may be involved in retaining cell stemness (Schlotzer-Schrehardt et 
al., 2007). 
3. Insult to the niche and corneal limbal stem cell deficiency 
Corneal blindness is a condition currently affecting about 10 million people worldwide 
(Klenkler et al., 2005). Corneal damage and disease can be a result of LSC deficiency, which 
can be heritable or acquired. Limbal stem cell deficiency (LSCD) results from the loss or 
dysfunction of LSC, most often because of injury or inflammation (Dua et al., 2000). When 
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the corneal limbal stem cells are depleted below a certain threshold, the cornea becomes 
covered by an abnormal conjunctiva-like epithelium, a process termed “conjunctivalization.” 
As a result of LSC deficiency, neovascularization, chronic inflammation, recurrent erosions, 
ulceration and stromal scarring can occur, causing painful vision loss (Holland and 
Schwartz, 1996, Kenyon and Tseng, 1989). 
LSCD is classified as either primary or secondary. Primary LSCD is characterized by the 
absence of identifiable external factors and an insufficient microenvironment to support the 
LSCs. Primary LCSD is seen in hereditary aniridia, congenital erythrokeratoderma, keratitis 
with multiple endocrine deficiencies and inadequate nutrition or cytokine supply, 
neurotrophic keratopathy, peripheral inflammation, and sclerocornea (Puangsricharern and 
Tseng, 1995). Dysfunction/poor regulation of stromal microenvironment of limbal epithelial 
SCs results in gradual loss of the SC population or TAC generation and amplification. 
Secondary LSCD occurs following the destruction of LSCs by external factors such as 
trauma, chemical–acid or alkali or thermal injuries (Tseng, 1985), or ultraviolet and ionizing 
radiation (Fujishima et al., 1996); systemic conditions such as Stevens-Johnson Syndrome 
(SJS), or ocular cicatricial pemphigoid (OCP) (Pfister, 1994). 
3.1 Clinical conditions 
The corneal epithelium cannot be maintained or renewed in eyes with LSCD, and leads to 
chronic epithelial defects. As the condition progresses, punctate epithelial keratopathy may 
develop and lead to severe epithelial defect. Due to decreased healing ability, corneal 
epithelial defects may become persistent, which can lead to stromal scarring, ulceration, and 
perforation (Puangsricharern and Tseng, 1995). Conjunctivalization of the cornea may occur, 
where the corneal epithelium is replaced with a conjunctival epithelial phenotype (Huang 
and Tseng, 1991). Loose intercellular connections result in stippled or late staining with 
fluorescein, and a lack of normal hemidesmosomal attachments at the base of corneal 
epithelial cells (Dua and Forrester, 1990). The cause of the LSCD often dictates whether the 
disease is unilateral or bilateral (i.e., affecting one eye or both). 
3.1.1 Pathology of limbal stem cell deficiency and histologic, ultrastructural studies 
Currently, diagnosis of LSCD is based on clinical evaluation, although clinical signs and 
symptoms of LSCD are nonspecific and common to several ocular surface diseases. The 
disease manifests as epithelial defects, chronic inflammation, keratitis, vascularization, and 
fibrosis, ultimately resulting in corneal blindness. In the absence of specific markers for 
limbal stem cells, identification of conjunctival goblet cells on the corneal surface is used to 
demonstrate conjunctival epithelial ingrowth or growth of epithelia on the corneal surface 
and to confirm the diagnosis of LSCD (Tseng, 1989, Dua and Forrester, 1990, Pfister, 1994).  
Normal limbal architecture, with rows of palisades and a perilimbal vascular arcade, is 
usually best defined at the superior and inferior limbus. Definition of the palisades is less 
distinct nasally and temporally. Delicate changes such as staining of conjunctiva-derived 
cells on and across the limbus, which may be associated with a persistent epithelial defect, 
and other changes such as scarring, vascularization, or limbal hyperaemia, indicating 
chronic inflammation, can be seen in the early stages. SC deficiency following mild injury, a 
superficial or a disease process is slowly progressive, and loss of a segment of limbal 
epithelium may occur without significant damage to the substratum. A sheet of 
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conjunctival/metaplastic epithelium without any notable vascularization consequently 
covers the cornea (Dua, 1998). Other pathological conditions resulting from LSCD are 
abnormal conjunctival/metaplastic epithelium; tags of loose epithelium filaments with 
mucus, and recurrent erosions, with unstable tear film that readily takes up fluorescein dye 
(Huang and Tseng, 1991). 
In moderate to severe cases of SC deficiency, superficial and/or deep vascularization of the 
cornea occurs. Initially it is restricted to the segment with SC deficiency, but in later stages, 
the entire circumference may become involved. However, in moderate to severe cases of SC 
deficiency, epithelial cover of the denuded cornea is associated with encroachment of 
fibrovascular tissue of varying thicknesses (Kenyon and Tseng, 1989). In human eyes, ocular 
surface insult from chemical burns may go beyond damage to the limbal tissue, leading to 
long-term ocular surface damage. This damage may include distortion and dysfunction of 
proximal or distal bulbar conjunctiva, tarsal conjunctiva, and anterior orbital tissues, 
resulting in abnormalities in surface mucous secretion and wetting, cicatrizing of 
conjunctiva, symblepharon, and entropion (McCulley, 1990, McCulley et al., 1983, Grant and 
Kern, 1955).  
In summary, alkali burns are the commonest cause of severe LSCD, producing long-
standing and persistent changes, like epithelial hyperplasia, fibrosis, and inflammation of 
the ocular surface. Presence of goblet cells on the cornea confirms the diagnosis of LSCD, 
but their absence does not rule it out, and correlates presence or absence with prolonged 
interval and squamous metaplasia of the entire surface in such cases (Fatima et al., 2008).  
3.1.2 Accompanying neovascularization 
The cornea is avascular, but a wide variety of insults can cause capillary invasion from the 
limbal vascular plexus. This process of new blood vessel formation is termed as corneal 
neovascularization (NV) (Chang et al., 2001, Takahashi et al., 1999). The three major 
categories of corneal NV are superficial vascularization, fibrovascular pannus, and deep 
stromal vascularization. Superficial vascularization rarely causes a decrease in vision; 
however, the latter two types of corneal NV can lead to significant loss of vision if they 
involve the visual axis. The most frequent causes of corneal angiogenesis are injury and 
defective limbal stem cells. 
4. Putative mechanisms of LSCD and corneal neovascularization 
There is a delicate balance between angiogenic and anti-angiogenic factors in the cornea, 
which determines its vascularity or lack thereof. The normal cornea is avascular, and corneal 
epithelial stem cells may play a significant role in maintaining the angiogenic balance in 
favour of avascularity. Nevertheless, there are numerous pro-angiogenic factors that play 
key roles in pathologic corneal NV. A comprehensive review of all the factors was described 
by Lim  et.al, and included key factors and their possible mechanisms of action (Lim et al., 
2009). 
4.1 Angiogenic factors and anti-angiogenic factors  
Vascular endothelial growth factor (VEGF) is a protein that acts as a mitogen for vascular 
endothelial cells, stimulating these cells to divide and multiply. The most important member 
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of this group is VEGF-A, which has been shown to stimulate endothelial cell proliferation 
and migration. It also increases microvascular permeability. In rats with surgically induced 
LSCD, high levels of VEGF correlated with inflammation and corneal NV. The corneal NV 
was suppressed with the addition of anti-VEGF antibody (Amano et al., 1998). Other 
members of this family include VEGF-B, VEGF-C, VEGF-D, and placenta growth factor. 
Inflammatory cytokines, chemokines, and cell adhesion molecules (CAMs) play a significant 
role in inflammatory cell infiltration and angiogenesis. The inflammatory cytokine 
interleukin-1 (IL-1) interacts directly with endothelial cells to stimulate migration and 
proliferation. IL-6 can stimulate corneal and inflammatory cells, in a paracrine manner, to 
secrete VEGF (Biswas et al., 2006). Tumor necrosis factor- (TNF-) enhances leukocyte 
infiltration (Yoshida et al., 1997). Chemokines are a family of secreted proteins that act as 
chemoattractants for inflammatory cells through activation of chemokine receptors. They 
may also enhance endothelial cell chemotaxis and proliferation (Berger et al., 1999). The 
chemokines IL-8 (Strieter et al., 1992, Koch et al., 1992) and monocyte chemoattractant-1 
(MCP-1) (Goede et al., 1999) have been shown to induce corneal NV in rabbit corneas. Cell 
adhesion molecules (CAMs) are proteins located on the cell surface involved in binding with 
other cells or with the extracellular matrix. They facilitate inflammatory cell infiltration into 
the corneal stroma by mediating the rolling, adhesion, or trans-endothelial migration of 
leukocytes (Vaporciyan et al., 1993). Fibroblast growth factors (FGF) are a family of heparin-
binding peptides that are expressed in tissues during angiogenesis, cellular differentiation, 
mitogenesis, and wound repair. Basic fibroblast growth factor (bFGF) is an angiogenic factor 
that exhibits differential binding of vascular basement membranes in newly formed corneal 
vessels, based on degree of maturation of the vessels (Soubrane et al., 1990). 
Several anti-angiogenic factors are produced by corneal epithelial cells, and a variety of 
vascular endothelial cell inhibitors including angiostatin, endostatin, restin, neostatin, and 
thrombospondins. Several of these endogenous anti-angiogenic factors are derived from the 
proteolysis of larger extracellular matrix proteins that have no intrinsic anti-angiogenic 
activity. Angiostatin, for example, is derived from the proteolysis of plasminogen.  
Endostatin is another example, produced by the cleavage of collagen XVIII. It inhibits 
proliferation (Hanai et al., 2002) and migration (Dhanabal et al., 1999) of endothelial cells 
(EC), and induces EC apoptosis. It may block the activation and catalytic activity of matrix 
metalloproteinases (MMPs) (Kim et al., 2000) and interfere with the binding of VEGF to its 
receptors. Arrestin, canstatin, and tumstatin, derived from collagen IV, also inhibit the 
proliferation and migration of ECs and induce EC apoptosis. Restin, which is related to 
endostatin, is produced by the proteolytic cleavage of collagen XV and is believed to inhibit 
EC migration (Ramchandran et al., 1999).  Neostatin, derived from collagen XVIII, and 
thrombospondin are other inhibitors of EC proliferation. 
Avascular tissue-derived factors, such as pigment epithelium-derived factor (PEDF), and 
angiogenic factor antagonists, such as angiopoetin-2, have been found in the cornea 
(Karakousis et al., 2001). PEDF and angiopoetin-2 inhibit angiogenesis by inhibiting 
endothelial cell migration and inducing EC apoptosis. 
4.1.1 Role of matrix metalloproteinases (MMPs) 
Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases. They are 
commonly categorized as collagenases, gelatinases, matrilysins, or membrane-type MMPs, 
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and they play a role in the proteolytic processes involved in angiogenesis (Chang et al., 
2001). Their action is inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). 
Some are involved in the cleavage process that generates the anti-angiogenic factors 
angiostatin and endostatin. Plasminogen activator inhibitors inhibit tissue plasminogen 
activator (tPA) and urokinase plasminogen activator (uPA), the activators of plasminogen, 
thereby preventing fibrinolysis and the physiologic breakdown of blood clots. 
In response to corneal injury, lipid mediators are released from cell membranes. Platelet 
activating factor (PAF) is a lipid mediator that facilitates endothelial cell migration through 
the cornea via increased expression of VEGF (Tao et al., 1996), MMP-9 (Tao et al., 1995), and 
uPA (Tao et al., 1996). Another important lipid mediator is 12(R)-HETrE, an arachidonic acid 
metabolite that binds to limbal endothelial cells and causes endothelial mitogenesis and 
neovascularization (Stoltz and Schwartzman, 1997). 
4.1.2 Animal disease models 
Development of experimental animal models to study ocular NV have been useful in 
understanding its mechanisms and pathogenesis, as well as to developing potential 
therapeutic modalities. For example, this basic research led to the discovery of new 
therapeutic targets for pathologic ocular NV (Barouch and Miller, 2006).  In the field of 
neovascular research, the testing of angiogenic and anti-angiogenic substances relies heavily 
on the sensitivity and specificity of in vivo and ex vivo bioassays.  
Several corneal angiogenesis models in the rabbit have been described, including direct 
intrastromal injections of substances like heparin-copper complex (Alessandri et al., 1983), 
induced chemical or thermal injury (Deutsch and Hughes, 1979, Korey et al., 1977), and 
intrastromal tumor implantation (Gimbrone et al., 1974). The cornea suture model created in 
mice and rabbits simulate a clinical scenario and are not expensive. However, models 
inducing an inflammatory component have disadvantages that are surgery dependent and 
yield highly variable responses. Recently developed micropocket assay models are not 
expensive, less time consuming; however, they are surgery dependent and yield highly 
variable responses (Rogers et al., 2007, Loughman et al., 1996). 
A conjunctivalized corneal epithelium lacks the smoothness and cohesion of normal corneal 
epithelium, making it optically inferior and prone to erosions. It is also heavily vascularized. 
To study inflammatory response, an important component of NV, Moromizato et al. 
produced burn and chemical cornea model lesions by corneal cauterization or local injection 
into the cornea of small amounts of acid (hydrochloric acid, 0.1 N) or alkali (sodium 
hydroxide, 0.1 N) (Moromizato et al., 2000). Complex pathophysiology is a disadvantage of 
this model. 
Animal models will continue to be needed for evaluation of safety and efficacy of 
combination therapies (Kim et al., 2006). Each model has strengths and weaknesses; thus, in 
order to gain the most useful information about the disease process and responses to 
therapy, the best approach may be combination of different models. Therefore, search for 
better, more reliable and reproducible animal models should continue. 
5. Treatment modalities 
A number of therapeutic strategies have been adopted to treat LCSD. In patients with partial 
limbal stem cell deficiency, mechanical debridement of the conjunctivalized epithelium can 
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be performed. This prevents conjunctival epithelium from crossing the limbus and allows 
the corneal epithelium to heal the defect. A groundbreaking report by Kenyon and Tseng, 
describes case studies where autologous limbal stem cell transplantation proved to be a 
powerful and effective surgical procedure to restore severely damaged ocular surfaces 
(Kenyon and Tseng, 1989). However, in later studies, where donor tissue was harvested in a 
“blinded” fashion, two surgical risks were identified. First, if the donor limbal grafts do not 
contain adequate numbers of stem cells, the surgery will either fail immediately or lack 
longevity. Second, if too many stem cells are removed, the donor eye will develop problems 
associated with LSCD (Copeland and Char, 1990, Holland and Schwartz, 1996, Holland, 
1996, Frucht-Pery et al., 1998). 
5.1 Amniotic membrane transplantation 
Human amniotic membrane (HAM) has several properties that render it extremely useful as 
a biomaterial for surgical purposes and it promotes epithelialization, inhibits fibrosis, has 
anti-inflammatory, anti-angiogenic, antimicrobial and antiviral properties, and has a high 
hydraulic conductivity (van Herendael et al., 1978, Gomes et al., 2005, Fernandes et al., 2005) 
Moreover, HAM shows low or no immunogenicity (Akle et al., 1985, Akle et al., 1981). Over 
the past decade, HAM’s abilities to reduce scarring and inflammation, and enhance wound 
healing, as well as its epithelialization properties, has led to an increase in its use as a 
biomaterial in ophthalmic surgery, particularly for ocular surface reconstruction. HAM has 
also been used to promote healing in corneal diseases such as chemical and thermal burns, 
neurotrophic ulcers, persistent epithelial defects, shield ulcers, microbial keratitis, band 
keratopathy and bullous keratopathy (Dua et al., 2004, Tosi et al., 2005a, Tosi et al., 2005b). 
Furthermore, the use of HAM as a biomaterial has not been confined to ophthalmologyit 
is also widely used in general surgery and wound treatment, e.g., for burned skin, bedsores, 
ulcers (Faulk et al., 1980), and in head and neck surgery (Zohar et al., 1987). More recently, 
HAM has been used as a culture substrate for ex vivo cultured LSC transplantation. 
5.1.1 Corneal limbal autografts and allografts 
The current treatment for LSCD is limbal transplantation using auto- or allograft limbal 
tissues, each of which have their associated risks and benefits. In 1989, Kenyon and Tseng, 
treated LSCD by transplanting healthy limbal tissue on diseased limbus, procedure termed 
as conjunctival limbal autograft (CLAU) and living-related conjunctival limbal autograft (lr-
CLAL) (Kenyon and Tseng, 1989). The main disadvantage of taking limbal tissue from the 
patient’s own contralateral healthy eye or from that of a living related donor is the risk of 
inducing LSCD in the donor eye, if a large amount of tissue is required (Jenkins et al., 1993). 
In bilateral cases with total LSCD, or in a one-eyed patient who develops total LSCD in the 
seeing eye, an allograft limbal transplant utilizing donor tissue from a cadaver or a living 
relative is the only option. A high risk of immune rejection is associated with such 
transplantation because of the vascularity of the limbus, the high immunogenic stimulus of 
the limbal transplant relative to the abundance of Langerhan’s cells and HLA-DR antigens. 
Hence, an effective immunosuppressant is essential indefinitely or until the graft is viable. 
Moreover, the dosage of immunosuppression can be increased or decreased if it proves 
ineffective or causes adverse effects, respectively (Tseng et al., 1998, Coster et al., 1995, Santos 
et al., 2005). For this reason, transplantation of auto-or allograft limbal tissues is not often a 
viable treatment option. 
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5.1.2 Ex vivo expansion of corneal limbal stem cells  
A novel method of transplanting limbal stem cells is ex vivo expansion of LSCs. This 
technique is based on Rheinwald and Green’s pioneering work in skin (Green et al., 1977). 
Skin epithelial cells have been grown successfully on a feeder layer of 3T3 fibroblasts that 
have been rendered mitotically inactive by irradiation or treatment with mitomycin C 
(Rheinwald, 1980). In the late 1990s, cultured autologous limbal epithelial cells were 
successfully used to improve vision in two patients with chemical injury-induced LSCD. 
From 1–2 mm2 limbal tissue, epithelial cells were isolated and expanded in the laboratory on 
tissue culture plastic, in the presence of growth-arrested 3T3 mouse fibroblast feeders, 
before transfer to the eye on a petrolatum gauze or a soft contact lens  (Pellegrini et al., 1997). 
This technique has theoretical advantages over conventional treatments. Its proposed 
advantage over CLAU and lr-CLAL is that the required size of the limbal biopsy is 
substantially smaller. This minimizes the risk of precipitating stem cell failure in the donor 
eye and provides the option of taking a further biopsy if required.  
Since 1997’s landmark report, a variety of culture techniques have been developed to 
produce contiguous epithelial cell sheets for transplantation. These techniques can be 
broadly defined as either explant culture in which cells migrate out from limbal tissue 
attached to a surface (Grueterich et al., 2002b, Koizumi et al., 2001a, Koizumi et al., 2001b, 
Sangwan et al., 2006) or suspension culture in which cells are released from enzymatically 
digested extracellular matrix before culture (Daya et al., 2005, Nakamura et al., 2006, 
Pellegrini et al., 1997). The aforementioned methods have been used in studies to culture 
limbal epithelial cells successfully, on either a growth-arrested 3T3 fibroblast feeder layer or 
an amniotic membrane (AM), with varying results (Kim et al., 2004, Zito-Abbad et al., 2006). 
5.1.3 Explant culture method 
The explant culture method involves plating a whole piece of limbal tissue or limbal 
explant, sized approximately 1 mm by 1 mm. One variation of the explant culture system 
uses AM, which acts as both a substrate and a carrier for the cultured cells. To attain growth 
from limbal explants the limbal biopsy is placed on the basement membrane surface of the 
amniotic membrane and allowed to adhere to it. Once attached, the biopsy and amniotic 
membrane are submerged in culture medium (Figure 3). This contains nutrients and 
mitogens that stimulate LSCs to proliferate and migrate out of the biopsy and cover the 
surface of the AM, which occurs over a period of 14 to 28 days.  
Recently, exciting discussions have led to the question of whether or not AM epithelial cells 
are necessary to cultivate limbal epithelial cells. Several groups have cultured limbal 
epithelial cells on intact AM (AM with amniotic epithelium) and have reported that these 
limbal epithelial cells contained slow-cycling and label-retaining characteristic cells, which 
did not express corneal epithelial differentiation proteins cytokeratin 3 (CK3) or  cytokeratin 
12 (CK12) and connexin 43. The amniotic epithelial cells were killed by cryopreservation and 
then removed by enzymatic digestion, chemical treatment, or physical scraping of the 
membrane prior to use (Koizumi et al., 2001a, Koizumi et al., 2001b, Nakamura et al., 2004b, 
Sangwan et al., 2005). Grueterich et al. demonstrated that culturing LSC on amnion with 
intact amniotic epithelium may result in a more stem cell-like phenotype than with de-
epithelialized amnion (Grueterich et al., 2002b). Their study showed that, while cells on both 
the substrates were well attached to the AM stroma, morphologically superior, better 
stratified and/or differentiated limbal cells could be cultured on denuded AM compared to 
those cells cultured on intact AM. As a result, these studies hypothesized that denuded AM 
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Fig. 3. The explant culture system. This method employs amniotic membrane as the carrier 
for cultured cells (A, Left); or cell culture insert (A-Right) as a substrate.  Phase contrast 
micrograph reveals LSC (black arrow) migrating out of the explants (red arrow) and 
covering the surface of the cell culture insert over the course of 14 to 28 days (B). 
is probably a more practical carrier for human limbal epithelial cell cultures in a cell-
suspension culture system. Kolli et al. analyzed the outgrowths from human cadaveric 
limbal explants cultured on AM by dividing the explant outgrowths into three zones—
inner, middle, and outer, depending on proximity to the explant. This yielded a successive 
decline in colony-forming efficiency (CFE), and ΔNp63ǂ and ABCG2 expression, and an 
increase in expression of CK3 in zones further away from the explants. These Results 
support the importance of putative niche environment in maintaining the undifferentiated 
state of the limbal stem cells during explant outgrowth  (Kolli et al., 2008). 
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5.1.4 Suspension culture system 
The cell suspension culture system employs the enzymes dispase, which digests basement 
membrane collagen and separates epithelial cells from the stroma, and trypsin, which 
separates clumps of limbal epithelial cells into a suspension of single cells (Figure 4). The 
single cells are then seeded either onto AM or onto a plastic tissue culture dish containing a 
feeder layer of growth-arrested 3T3 fibroblasts. Culture medium is then added, and the cells 
are incubated for 14 to 21 days. When confluent, the epithelial sheet is transferred to the 
ocular surface using either a contact lens or fibrin gel (Pellegrini et al., 1997, Pellegrini et al.,  
 
 
A 
 
B 
Fig. 4. The suspension culture system. This method employs the enzymes dispase and 
trypsin. This suspension is seeded onto either amniotic membrane (A, Left) or a plastic 
tissue culture dish that contains a feeder layer of growth-arrested 3T3 fibroblasts (A, Right). 
Phase contrast micrograph of limbal epithelial colonies on 3T3 cells (B).  
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1999). Recently, Di Girolamo et al. cultured limbal epithelial cells in autologous serum, on 
lotrafilcon A and balafilcon A contact lenses. The cells cultured on the lotrafilcon A contact 
lenses proliferated, migrated, showed a corneal phenotype and microvillae on the apical 
surface; whereas cells cultured on balafilcon A contact lenses showed no growth (Di 
Girolamo et al., 2007).  
Various substrates have been used in suspension culture systems for proliferation of limbal 
epithelial cells, for example, reconstituted collagen substrate membrane from HAM (Merrett 
et al., 2008), a chitosan cross-linked collagen membrane (Auxenfans et al., 2009), which has 
good adherence, retains epithelial morphology and supports the nontoxic nature of the 
membrane. Reconstituted human amniotic collagen membrane has been used to act as 
collagen scaffolding for the culture of limbal epithelial cells (Doillon et al., 2003, Griffith et 
al., 1999, Li et al., 2005). Rama et al. have provided data demonstratng that the use of fibrin as 
a carrier supports stem cell maintenance (Rama et al., 2001). 
5.1.5 Variations in explant and suspension cultures 
The variations in explant and cell suspension culture systems are airlifting and/or (with or 
without the addition) of 3T3 feeder cells. In airlifting cultures, the level of culture medium in 
the dish is lowered to the surface level of the epithelium, promoting stratification and 
differentiation of the epithelium (Ban et al., 2003, Cooper et al., 2004, Koizumi et al., 2001a, 
Nakamura et al., 2003b). This method can, therefore, be used for investigating the 
stratification and differentiation potential of cultured limbal epithelial cells with high 
expression of CK3 and CK12. The latter culture method, adding 3T3 feeder cells as an 
additional feeder layer of growth-arrested 3T3 fibroblasts in the bottom of the cell culture 
well is a duplex system (Miyashita et al., 2008). 3T3 fibroblasts are primitive cells isolated 
from embryonic mice. They have a high proliferative capacity and have been used 
extensively in the culture of epithelial stem cells especially in skin and cornea. Both amniotic 
membrane and growth-arrested 3T3 fibroblasts inhibit the differentiation of corneal 
epithelial cells ex vivo, which allows the expansion of the population of LSCs (Grueterich et 
al., 2003, Pellegrini et al., 1999). Denuded AM is thought to be an excellent substrate for the 
corneal limbal cell culture used for ocular surface reconstruction, even though AM epithelial 
cells contain various growth factors with 3T3 feeder cells. This theory, however, remains to 
be fully investigated. 
The variation in suspension culture techniques are use of novel temperature-responsive 
culture surfaces. Temperature-responsive polymers chemically immobilized to thin films on 
cell-culture surfaces facilitate cell adhesion and growth of cells in normal culture conditions, 
at 37°C. Temperatures below 30°C can reversibly alter cell hydration properties with respect 
to temperature, hydration and swellingprompting complete detachment of adherent cells 
without the use of proteolytic enzymes or treatment with EDTA (Nishida et al., 2004b, 
Nishida et al., 2004a). The advantage of this system is that no enzymes are needed to free the 
epithelial sheet from the culture membrane; however, application of temperature-responsive 
polymers in a clinical setting remains questionable for safety and efficacy. 
6. Ex vivo expansion of alternative sources of epithelium 
Although adult stem cells hold considerable promise for the treatment of a number of 
diseases in regenerative medicine, the second major obstacle has been to obtain sufficient 
number of autologous or allogeneic stem cells.  
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6.1 Oral mucosal cells 
In an attempt to overcome the problems inherent in the transplantation of allogeneic tissue, 
there has been recent interest in the possibility of using alternative autologous epithelial 
cells. There are several potential sources of non-keratinizing, stratified squamous epithelium 
in the adult human, including oral mucosal, conjunctival, nasal, esophageal, vaginal and 
rectal epithelia. The main concept is to use the smooth surface of the oral mucosa, with its 
stem cell properties, to reconstruct the ocular surface. Oral mucosae are thought to be at a 
lower stage of differentiation than epidermal keratinocytes (Collin et al., 1992, Schermer et 
al., 1986) because they divide rapidly and can be maintained in culture for prolonged 
periods without keratinization (Hata et al., 1995). Various antimicrobial peptides (AMPs) are 
known to be present on the epithelial cells of ocular and oral surfaces (Haynes et al., 1999). 
Moreover, keratin 3 is expressed by both corneal epithelium (Sangwan et al., 2003b) and oral 
mucosa (Collin et al., 1992, Juhl et al., 1989), suggesting that gene expression in oral and 
corneal epithelium may be similar. Wet-surfaced epithelia, produce a group of highly 
glycosylated, protective membrane glycoproteins termed mucins (Gipson, 2007). Although 
the function of these mucins in the oral cavity remains to be elucidated, it is possible that 
they contribute to the epithelial protective mucin layer and act as receptors initiating one or 
more intracellular signal transduction pathways (Argueso et al., 2003). At the ocular surface, 
at least three membrane-associated mucins (MUC1, -4, and -16) and two secreted mucins 
(MUC5 and -7) are expressed (Hori et al., 2007).  
More extensive studies have been performed to check the feasibility of using cultivated oral 
mucosal epithelium (COME) for this purpose, as it is readily available and could be 
harvested without invasive surgery. A small biopsy of the patient’s oral mucosa is 
harvested, connective tissue is dissected and, after enzymatic digestion, an epithelial cell 
suspension is prepared. The oral epithelial cells are cultivated on the substrate with a feeder 
layer. The sheet of cultivated cells is then transplanted onto the diseased ocular surface 
(Figure 5). These studies suggest that oral mucosal epithelium is a feasible alternative for  
 
 
Fig. 5. Systematic representation of cultivated oral mucosal epithelium transplantation. 
Adopted from (Lim et al., 2009). 
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allogenous limbal transplants (Nakamura et al., 2003b, Nakamura et al., 2004a, Inatomi et al., 
2006, Nishida et al., 2004b, Hayashida et al., 2005). Oral mucosal epithelium cultured on 
human amniotic membrane with the help of feeder cells has been characterized extensively, 
and has been used to reconstruct the ocular surface in rabbits (Nakamura et al., 2003a) as 
well as humans with chemical injury and SJS (Nakamura et al., 2004a). In the lengthiest 
study reported so far, cultured oral mucosal epithelial cells were transplanted into patients 
with LSCD and followed up with for up to 34 months (Inatomi et al., 2006) where the 
followups continued until tissue became viable. 
The main advantages of using oral mucosa are the absence of tissue rejection and, therefore, 
avoidance of immunosuppression; easy access to the oral cavity; inconspicuous location of 
the resultant small scar, and repeatability. This treatment method has not, however, 
provided satisfactory long-term results. The oral mucosal epithelial cell grafts seldom 
transdifferentiate to a corneal epithelium phenotype, e.g., expression of keratin 12 (Krt12) 
(Inatomi et al., 2006). This new approach, however, provides an exciting possibility for 
treatment of this difficult group of patients with blindness from bilateral total LSCD and 
warrants further study. 
6.1.2 Dental pulp stem cells 
In an attempt to prevent rejection, isolated human immature dental pulp stem cells 
(hIDPSC) from deciduous teeth have been used as an autologous alternative epithelium 
source for LSCD treatment or corneal reconstruction. hIDPSCs are known to express both 
mesenchymal stem cell markers (SH2, SH3 and SH4) and human embryonic stem cell 
markers (OCT 4, NANOG, SSEA-3 and SSEA-4) (Gomes et al., 2010). Furthermore, hIDPSCs 
have a normal karyotype and show the capacity for multilineage differentiation into 
neurons, smooth and skeletal muscle, cartilage, bone, and other cell types ex vivo and in vivo 
(Kerkis et al., 2006, Lavagnolli et al., 2009). Limited studies have been performed to test 
dental pulp stem cells as potential treatment for LSCD. Monteiro et al. demonstrated, using 
immunohistochemistry and reverse transcription polymerase chain reaction, that hIDPSCs 
express markers in common with LSCs, such as ABCG2, integrin ǃ1, vimentin, p63, 
connexin 43 and cytokeratins 3/12. These have been shown to be capable of reconstructing 
the eye surface after induction of unilateral total LSCD in rabbits (Monteiro et al., 2009). 
Further studies are required to understand the long-term outcome of LSCD treated using 
hIDPSCs. 
6.1.3 Hair follicle stem cells 
Hair has the potential to regenerate from stem cells located at the lower part of the follicle 
called the bulge (Oshima et al., 2001). Additionally, hair follicle stem cells (HFSCs) can give 
rise to epidermis and sebaceous gland tissues. Recently, Blazejewska et al. demonstrated that 
murine HFSCs can transform into epithelia-like cells when cultured in limbal fibroblast-
derived medium (Blazejewska et al., 2009). Although, these findings need further 
substantiation using in vivo functional studies in animal models, they provide the first step 
towards the design of protocols that could use human autologous hair follicle stem cells  
to replace corneal epithelium in therapeutic applications. Due to their multipotency,  
easy accessibility, and high proliferation rate ex vivo, hair follicles are an attractive source  
of autologous adult stem cells and a promising therapeutic tool for ocular surface 
reconstruction. 
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6.1.4 Embryonic stem cells 
Embryonic stem cells (ESCs) are pluripotent (i.e., they can give rise to any cell type in the 
body) and are derived from the inner cell mass of a blastocyst. Differentiation of ESCs to a 
corneal epithelial lineage could be achieved by replication of the LSC niche environment. 
Transplantation of epithelial cells derived from mouse ESCs have been used to reconstruct 
chemically injured mouse corneas (Homma et al., 2004). Moreover, human ESCs express 
cornea-like epithelial markers such as CK3 and CK12 when cultured in conditions similar to 
those of the limbal stem cell niche. Ex vivo replication of the LSC niche environment has been 
achieved by culturing hESCs on an extracellular matrix of collagen IV and fed with medium 
conditioned with limbal fibroblasts (Ahmad et al., 2007). The differentiated human ESCs 
demonstrate phenotypic differences to cultured human limbal epithelial cells, such as 
differences in size and cilia length, which are characteristically much longer than those of 
limbal epithelial cells. These data suggest that some differences exist between LSCs and hESC-
derived corneal progenitors (Ahmad et al., 2007). The translation of this approach to human 
therapeutic use requires further work to overcome problems associated with functionality, 
complete hESC differentiation and immune rejection as well as ethical concerns. 
7. Future considerations for cultivated epithelial transplants 
Ex vivo expansion of limbal epithelium has been performed by several unrelated groups in a 
number of countries and used to treat a variety of ocular surface disorders that are thought 
to be the result of limbal stem cell failure. Despite a substantial number of experimental 
models of this technique and an ever-growing body of laboratory data on limbal epithelial 
stem cell biology, scientific basis for this procedure is poorly understood. Future 
considerations in the field of limbal epithelial cell culture and transplantation methods are 
discussed below. 
7.1 Culture methodologies 
The culture of limbal epithelium is essential for furthering our understanding of limbal stem 
cell biology. Ex vivo expansion of LSCs for the treatment of LSCD is one of the more recent 
stem cell treatments available in the field of regenerative medicine. Although the technique 
of ex vivo expansion of LSCs is still in its infancy, it is starting to be used by several groups 
for clinical purposes, and different approaches have been attempted. There are many 
varying techniques for culturing limbal epithelial cells, such as different media and sera; 
culture with 3T3 fibroblasts or amniotic membrane, or both; removal of amniotic membrane 
epithelial cells from the membrane, or not; use of explant or suspension methods; and 
airlifting of the culture, or not (Shortt et al., 2007, Grueterich et al., 2003). Whichever culture 
method is used, the end result, often after a period of weeks, is a cultivated epithelial sheet 
composed of LSCs. The ease of explanting culture technique could be adapted without 
initial dispase treatment for transplantation studies. However, further studies on the 
interaction between epithelial progenitor and autologous stromal cells ex vivo, and complete 
characterization of limbal cells in this culture system, including cell junction proteins, are 
required. 
7.1.2 Autologous sources and xenobiotic-free conditions 
With growing concerns regarding the potential transmission of opportunistic agents such as 
prions and animal viruses, it would be preferable to culture cells for human transplantation 
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under xenobiotic-free conditions. In limbal corneal epithelial cultures, the use of autologous 
human serum in the medium and/or human amniotic membrane would be appropriate as it 
would reduce the need for animal cells or products in the culture (Kolli et al., 2010, 
Nakamura et al., 2004a, Nakamura et al., 2006). To avoid contamination from xeno-feeder 
layers, different human feeder layers have also been developed and analyzed (Chen et al., 
2007). Moreover, cells have been cultured on feeder layers during the proliferative phase 
and further separated using robotic technology (Schneider et al., 2008). Limbal epithelial 
cells grown with MRC–5 human embryonic fibroblasts can sustain the stem cell phenotype 
(Notara et al., 2007). The successful use of autologous serum–derived oral epithelial 
equivalent to treat severe ocular surface disease was reported in 2006 (Ang et al., 2006, 
Nakamura et al., 2006). This represents an important advance in the pursuit of completely 
autologous xenobiotic-free bioengineered ocular equivalents for clinical transplantation.  
In conclusion, a specific culture system that mimics natural tissue architecture and its niche 
closely by enabling formation of an autofeeder layer, thereby eliminating the need for xeno-
feeder layers for ex vivo expansion of epithelial progenitor cells is important.  
7.1.3 Combination techniques with anti-angiogenic treatments 
Angiogenic and anti-angiogenic cytokines are involved in cell migration and differentiation 
in wound healing and tumor progression (even in the absence of angiogenesis). The ever-
increasing use of anti-angiogenic therapy for corneal neovascularization brings great 
promise for the treatment of a wide variety of corneal conditions, including LSCD. TGF-ǃ, 
IL-1, and VEGF are the key pro-angiogenic factors involved in the process of angiogenesis; 
and are targets for anti-angiogenic therapies. The ultimate goal for research on corneal 
angiogenesis is to discover effective treatment for pathological corneal neovascularization; 
however, to date, most anti-angiogenic therapies remain experimental. 
Angiostatin, a 38 kDa proteolytic fragment of plasminogen, is a potent anti-angiogenic 
factor. Recombinant angiostatin has been used successfully to suppress tumor growth and 
metastasis in animal model systems (Shin et al., 2000, Ambati et al., 2002). Gabison and 
associates have demonstrated the involvement of angiostatin in corneal avascularity after 
wounding. They confirmed that angiostatin-like molecules are expressed in the corneal 
epithelium and in cultured corneal epithelial cells (Gabison et al., 2004). Corneal 
neovascularization was observed after excimer laser keratectomy when anti-angiostatin 
antibodies were injected into the cornea; this was significantly higher than when plasmin B 
chain antibodies were injected. These studies suggest that angiostatin may contribute to the 
maintenance of corneal avascularity after excimer laser keratectomy.  
The corneal epithelium may be the source of anti-angiogenic molecules. It has long been 
demonstrated that corneal epithelium inhibits angiogenesis (Kaminski and Kaminska, 1978). 
Ferreras and associates demonstrated the generation of endostatin-like fragments by 
cleaving collagen XVIII with MMP-2, -3, -9, -12, -13, or -14 (Ferreras et al., 2000). 
Upregulation of matrix-derived anti-angiogenic factors such as endostatin (Kato et al., 2003) 
and restin (Saika et al., 2004), along with increased anti-inflammatory factor IL-1ra may play 
an important role in LSC and AM transplantation-mediated anti-angiogenic effect. Recently, 
Cursiefen et al. demonstrated a critical mechanism that contributed to corneal avascularity 
by VEGF receptor 3, which is normally present on lymphatic and proliferating blood 
vascular endothelium, is strongly constitutively expressed by corneal epithelium and is 
mechanistically responsible for suppressing inflammatory corneal angiogenesis (Cursiefen 
et al., 2006). Knowledge gained from using epithelia–matrix interaction to regulate corneal 
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angiogenesis will enable us to optimize the anti-angiogenic effect of the cultivated cells like 
oral mucosal epithelial cells or mesehchymal stem cells for future ocular surface 
reconstruction. 
8. Clinical trials and outcomes: present and future  
LSCD by any cause may result in poor corneal epithelialization, persistent epithelial defects, 
corneal vascularization, corneal scarring, and so-called conjunctivalization of the cornea. 
These problems may in turn lead to decreased vision, ocular discomfort and pain, as well as 
an unstable ocular surface. Limbal stem cells may be partially or totally depleted, resulting 
in varying degrees of stem cell deficiency and resulting abnormalities on the corneal surface.  
The first use of ex vivo expanded LSCs for the treatment of LSCD in human subjects was 
described by Pellegrini and co-workers, who used a culture system of LSCs grown on mouse 
J2-3T3 fibroblasts with fetal calf serum (FCS) supplemented media (Pellegrini et al., 1997). Since 
then, several studies have been reported on the transplantation of ex vivo cultured LSCs to treat 
LSCD (Schwab et al., 2000, Tsai et al., 2000, Koizumi et al., 2001b, Grueterich et al., 2002a). 
Schwab et al. reported the results of treating 19 eyes of 18 patients (Schwab, 1999). In 2003, 
Sangwan et al. reported the largest study to date, which enrolled 125 patients (Sangwan et al., 
2003b). In this study ex vivo cultured limbal and conjunctival epithelial cells were grown on 
AM. In 2006, Sangwan et al. published a more detailed report on clinical outcomes for 88 eyes 
of 86 patients (Sangwan et al., 2006). In 2001, Rama et al. reported treatment outcomes for 18 
eyes of 18 patients (Rama et al., 2001). The same group recently reported a 10 year follow-up 
with permanent restoration of transparent corneal epithelium in 76.6% of eyes, with few 63 
instances of inflammation out of 113 eyes treated (Rama et al., 2010). The outcome of cultured 
limbal stem cells transplants differed significantly depending on whether the transplanted 
cultures contained more than 3% p63-bright holoclone-forming stem cells or 3% or less — the 
success rates were 78% with the larger number of stem cells and 11% increase with the smaller 
number of p63 cells (Rama et al., 2001, Rama et al., 2010), suggesting the importance of a high 
percentage of p63 in cultured limbal stem cells. The remaining studies each treated between 2 
and 14 patients (Kolli et al., 2010, Grueterich et al., 2002b, Nakamura et al., 2004a, Sangwan et 
al., 2003a).  
In total, current  studies reported data to enable analysis of outcomes in 506 eyes (Baylis et 
al., 2011) treated using ex vivo, cultured LSC transplants and 27 eyes treated with ex vivo 
cultured oral mucosal epithelium. To date, the limited periods (mean follow-up was 16.74 
months, median 14 months, range 6 to 29.5 months), the use of subjective outcome 
measures, and the absence of a reliable method for detecting transplanted (stem) cells shows 
that a long term success rate has yet to be established. 
Ex vivo expansion and transplantation of limbal epithelium have been performed by several 
unrelated groups in a number of countries, with uncertainty in the limbal stem cell 
cultivation, with different variables, including source of donor limbal tissue, culture method 
(e.g., suspension versus explant culture), culture composition (e.g., 3T3 fibroblasts, amniotic 
membrane and fibrin), and variation in culture time. Overall the success rate for cultured 
limbal epithelial transplantation is 76%. This is based on clinical restoration of the corneal 
epithelium. It is interesting that, despite the different methodologies employed, the success 
rates and number of significant clinical outcomes are remarkably high. It would, therefore, 
appear that, as long as viable limbal epithelial stem cells are transferred, the method used to 
achieve this is relatively unimportant. 
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The future directions in LSC transplantation involve modifications of existing technologies 
to allow improved safety and efficacy of techniques at hand.  The studies on the molecular 
mechanism of limbal stem cells and their niche will enhance our knowledge of how cell 
therapy can be further modified to closely mimic in vivo conditions. Identification of key 
niche factors controlling limbal stem cell behaviour would allow these conditions to 
replicate ex vivo and, thus, make the process of culturing limbal stem cells safer and more 
efficient. Newly developed transplantation techniques using tissue-engineered epidermal 
adult stem cells, immature dental pulp stem cells (Gomes et al., 2010), and hair follicle bulge-
derived stem cells (Blazejewska et al., 2009) were reportedly successful for the reconstruction 
of corneal epithelium in an animal model of severe LSCD. The recombinant human cross-
linked collagen scaffold and a Food and Drug Administration-approved contact lens are 
also promising new techniques for successfully achieving ocular surface reconstruction (Di 
Girolamo et al., 2007). There are main challenges in improving the established techniques, in 
elimination of animal-derived products and minimization of allogeneic human tissue use.  
Since cell-based therapies are being scrutinized by ever-increasing regulatory requirements, 
many investigators that have been successfully performing ex vivo cultivation in the past 
are reformulating their methodologies to conform to these guidelines (Daniels et al., 2006, 
Kolli et al., 2010). The future of this methodology lies in the standardization of the stem cell 
preparation and cultivation techniques with clearly defined endpoints and outcome 
measures of treatment success.  
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